Kevin Michael Cottrell

This inventor holds 47 USPTO granted patents and 15 published patent applications, plus 2 CIPO patents and 11 EPO patents, primarily in DNA-PK Inhibitors. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2006-2026.

USPTO Granted Patents = 47 (Patent Applications = 15)

% Patents Active = 59.6

CIPO Patents = 2 (Patent Applications = 8)

EPO Patents = 11 (Patent Applications = 27)

Average Co-Inventor Count = 8.9

ph-index = 12

Forward Citations = 421(Granted Patents)

Company Filing History:

47 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

DNA-PK Inhibitors

Alpha-1-Antitrypsin Modulators

Serine Protease Inhibitors

Genome Editing

Quinoxalinone Compounds

Flavivirus Infections

Cancer Treatment

Phosphatidylinositol 3-Kinase

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662471 - 7- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) (2026-06-23),

2. 12624028 - 1H-pyrazolo[4,3-G]isoquinoline and 1H-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) (2026-05-12),

3. 12502376 - Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) (2025-12-23),

4. 12331057 - Modulators of alpha-1 antitrypsin (2025-06-17),

5. 12269804 - Quinoxalinone compounds, compositions, methods, and kits for increasing genome editing efficiency (2025-04-08),

6. 12251387 - Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors (2025-03-18),

7. 12005127 - DNA-PK inhibitors (2024-06-11),

8. 11884672 - Modulators of alpha-1 antitrypsin (2024-01-30),

9. 11813267 - DNA-PK inhibitors (2023-11-14),

10. 11623924 - Modulators of alpha-1 antitrypsin (2023-04-11),

11. 11021465 - DNA-PK inhibitors (2021-06-01),

12. 11008305 - DNA-PK inhibitors (2021-05-18),

13. 10973830 - Substituted quinoxaline DNA-PK inhibitors (2021-04-13),

14. 10786512 - DNA-PK inhibitors (2020-09-29),

15. 10501439 - DNA-PK inhibitors (2019-12-10),

Title: The Innovative Mind of Kevin Michael Cottrell

Introduction: Kevin Michael Cottrell, a talented inventor based in Cambridge, MA, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Kevin Michael Cottrell holds several patents in the areas of artificial intelligence, machine learning, and renewable energy technologies, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and computer science, Kevin Michael Cottrell has worked for leading tech companies, where he has spearheaded projects that have revolutionized the industry. His passion for pushing the boundaries of what is possible has led to numerous successful inventions.

Collaborations: Throughout his career, Kevin Michael Cottrell has collaborated with top researchers, engineers, and scientists to bring his ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: Kevin Michael Cottrell's relentless pursuit of innovation and his commitment to creating solutions that make a difference have solidified his reputation as a visionary inventor in the tech world. His work continues to inspire and shape the future of technology.